Biocom’s top priority is the safety of our members and the well-being of our employees. After careful consideration, Biocom has decided to transform our 2021 Global Life Science Partnering Conference to a fully virtual event. We know that many lives are being impacted and disrupted by COVID-19 and we are grateful to be able to continue offering our members valuable content in a safe manner.
Venture Partner, ARCH Ventures
Tom has contributed to innovative healthcare solutions as a practicing physician, scientist, educator, research executive and entrepreneur. Currently a Venture Partner at ARCH Venture Partners, he previously led Research & Early Development at Celgene Corporation, where he and colleagues established new corporate collaboration approaches and discovered and advanced to approval multiple impactful medicines in oncology and inflammatory diseases. Formerly in senior R&D leadership positions at Immunex, Amgen, and AmbRx, he currently Chairs Locana Bio, and serves as Director at Magenta Therapeutics, Zafgen, Vividion, and Gossamer Bio. He chairs the Board of Overseers of The Scripps Research Institute, advises Vanderbilt University Medical Center, the Parker Institute for Cancer Immunotherapy, is a Trustee of Reed College, and serves as Director for the Lupus Research Alliance. He obtained his undergraduate degree at Southern Methodist University, his medical degree at UT-Southwestern Medical School, trained in Internal Medicine at Massachusetts General Hospital, and was formerly Hakim Professor of Medicine at Vanderbilt.